Juergen Faiss

7T MRI in natalizumab-associated PML and ongoing MS disease activity

Thoralf Niendorf, Ralf Mekle, Friedemann Paul, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Margaret Burnett, Gavin Giovannoni, 2018, The Lancet.